Catheter and Surgical Therapies for Atrial Fibrillation (CAST-AF) | Heart Rhythm Society

Catheter and Surgical Therapies for Atrial Fibrillation (CAST-AF)

Catheter and Surgical Therapies for Atrial Fibrillation (CAST-AF)

This continuing medical education initiative provides a day and a half of presentations and interactive, live activity developed and delivered by internationally recognized thought leaders in the field of atrial fibrillation. We will be using a hybrid format again this year, hosting in-person attendees and providing a virtual platform to allow attendance for those who wish to join virtually. Likewise, this year's agenda will consist of lectures and live panel discussions. There will also be concurrent breakout sessions under two tracks - Electrophysiology and Cardiac Surgery.

Course Directors

Bradley Knight, MD, FHRS
Patrick McCarthy, MD
James Cox, Jr., MD
Susan Kim, MD
Rod Passman, MD, FHRS

Learning Objectives
  • Discuss the electrophysiology of atrial fibrillation.
  • Cite the newest concepts of atrial electrophysiology, including differences in endocardial and epicardial conduction patterns and how they can impact the interpretation of electrophysiologic mapping.
  • Identify the advantages and limitations of activation-time mapping, voltage mapping, and phase mapping for the analysis of the electrophysiology of atrial fibrillation.
  • Demonstrate improved outcomes for the catheter ablation of atrial fibrillation using the most advanced techniques.
  • Demonstrate improved outcomes for the surgical ablation of atrial fibrillation using the most advanced techniques.
  • Discuss the electrophysiological basis of catheter ablation for paroxysmal and non-paroxysmal atrial fibrillation.
  • Cite the current indications for catheter ablation of atrial fibrillation in paroxysmal and non-paroxysmal atrial fibrillation.
  • Explain the current results of catheter and surgical ablation for paroxysmal and non-paroxysmal atrial fibrillation.
  • Implement a safe and effective left atrial appendage closure program using current percutaneous and surgical techniques to reduce the risk of stroke in patients with atrial fibrillation.
  • Determine the limitations of the HRS definitions of success and failure for the interventional (catheter and surgical) treatment of atrial fibrillation.
  • Examine the differences in the electrophysiology of primary (“stand-alone”) and secondary (“concomitant”) atrial fibrillation.
  • Discuss the electrophysiological basis of concomitant surgical ablation for atrial fibrillation in patients undergoing valve surgery with or without coronary artery disease.
  • Review the surgical options for the treatment of atrial fibrillation in patients undergoing mitral valve, aortic valve, and/or coronary artery bypass surgery.
  • Restate the currently recommended surgical lesion patterns for the concomitant surgical treatment of atrial fibrillation in patients undergoing mitral valve, aortic valve, and/or coronary artery bypass surgery based on recent clinical trial results.
  • Improve the outcomes of patients undergoing catheter and surgical therapies for atrial fibrillation using lifestyle modifications targeting obesity and other risk factors.
Target Audience
  • Cardiologists
  • Cardiovascular Surgeons
  • Clinicians
  • EPs
  • Fellows-in-Training
  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists
  • Technicians
  • Researchers
Date and Time August 26-27, 2022
11:45 am - 6:00 pm
Location

Chicago, Illinois United States of America

Topics
Ablation
Allied Professional
Atrial Arrhythmias
Atrial Fibrillation
Clinical EP
Device Therapy
Our Sponsors
Northwestern University